Silverback Therapeutics

$37.26
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.30 (-3.34%) Today
-$0.38 (-1.01%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell SBTX and other stocks, options, and ETFs commission-free!

About SBTX

Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases.

CEO
Laura K. Shawver
Employees
54
Headquarters
Seattle, Washington
Founded
2016
Market Cap
1.15B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
156.39K
High Today
$39.36
Low Today
$36.58
Open Price
$39.36
Volume
131.63K
52 Week High
$63.41
52 Week Low
$24.22

SBTX Earnings

-$1.37
-$0.91
-$0.46
$0.00
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, After Hours

You May Also Like

VTRS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure